干旱区生态环境知识资源中心(Arid): Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study

Arid

DOI	10.14309/01.ajg.0000592592.12499.dd
	Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
	Chiorean, Michael; Vermeire, Severine; Panes, Julian; Peyrin-Biroulet, Laurent; Zhang, Jinkun; Sands, Bruce E.; Lazin, Krisztina; Cabell, Chris H.; Naik, Snehal U.; Klassen, Preston; Sandborn, William J.
来源期刊	AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN	0002-9270
EISSN	1572-0241
出版年	2019
卷号	114 页码:S445-S446
类型	Meeting Abstract
语种	英语
开放获取类型	Bronze
收录类别	SCI-E
WOS记录号	WOS:000509756001380
WOS类目	Gastroenterology & Hepatology
WOS研究方向	Gastroenterology & Hepatology
资源类型	期刊论文
条目标识符	http://119.78.100.177/qdio/handle/2XILL650/369931
作者单位	[Chiorean, Michael] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Vermeire, Severine] Univ Hosp, Leuven, Vlaams Brabant, Belgium; [Panes, Julian] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Catalonia, Spain; [Peyrin-Biroulet, Laurent] Lorraine Univ, Vandoeuvre Les Nancy, Lorraine, France; [Zhang, Jinkun; Cabell, Chris H.; Naik, Snehal U.; Klassen, Preston] Arena Pharmaceut, San Diego, CA USA; [Sands, Bruce E.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Lazin, Krisztina] Arena Pharmaceut, Zug, Switzerland; [Sandborn, William J.] Univ Calif San Diego, La Jolla, CA 92093 USA
推荐引用方式 GB/T 7714	Chiorean, Michael,Vermeire, Severine,Panes, Julian,et al. Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study[J],2019,114:S445-S446.
APA	Chiorean, Michael.,Vermeire, Severine.,Panes, Julian.,Peyrin-Biroulet, Laurent.,Zhang, Jinkun.,...&Sandborn, William J..(2019).Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study.AMERICAN JOURNAL OF GASTROENTEROLOGY,114,S445-S446.
MLA	Chiorean, Michael,et al."Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study".AMERICAN JOURNAL OF GASTROENTEROLOGY 114(2019):S445-S446.